ABSTRACT A defect in the proliferative capacity of satellite cells, mononucleated precursors of mature muscle fibers, was found in clonal analyses of cells cultured from Duchenne muscular dystrophy (DMD) patients. The total yield of myoblasts per gram of muscle biopsy was decreased to 5% of normal. Of the DMD myoblast clones obtained, a large proportion -contained a morphological class of flat distended cells that had an increased generation time and ceased to proliferate beyond 100-1,000 cells but could be induced to fuse and form myotubes. The altered muscle phenotype was detected in all cultures from DMD patients but was rarely found among myoblasts of controls. By age 14 yr, it comprised as many as 90% of DMD myoblasts. The remaining DMD myoblast clones, which initially grew well, had severely impaired proliferative capacity upon passage and further cultivation. Eventually all myoblasts from DMD muscle tissue exhibited defective growth potential. In contrast, the fibroblast yield and proliferative capacity from DMD samples did not differ from normal. Based on these findings, we propose a hypothesis for the etiology of DMD: Dividing myoblasts are required for muscle growth and maintenance, and the limited capacity of DMD myoblasts to grow is directly related to the progressive muscle degeneration characteristic of the disease.
Duchenne muscular dystrophy (DMD) is a chronic, lethal Xlinked disease that affects 1 in 4,800 males (1) . Although DMD is well defined clinically, the cellular and biochemical basis for the disease is unknown. A major problem in the biological study of muscular dystrophy has been the heterogeneous nature of muscle tissue. Muscle is composed of a mixture of cell types present in variable ratios, especially in disease states. When muscle is dissociated and the cells plated in culture, both myoblasts and fibroblasts are obtained and the rate of proliferation of the fibroblasts frequently exceeds that of the myoblasts. DMD muscle cultures have been compared with normal muscle cultures and a number of differences reported, including increased collagen synthesis (2) , decreased specific activity of creatine kinase (3), increased ratio of nonmuscle to muscle creatine kinase isozymes (3) (4) (5) , altered lipid biosynthesis (6) , and clustered myotube morphology (5, 7, 8) . However, it is unclear whether these differences are intrinsic to the DMD myoblasts and related to the disease or a reflection of the proportion of fibroblasts present in the mixed cultures analyzed.
We have developed methods for obtaining pure populations of human myoblasts that can be studied under standardized conditions (9) . Our methods use postnatal muscle as a source.
Consequently, the myoblasts obtained in culture are muscle satellite cells, the mononucleated myoblasts of mature muscle fibers, positioned between the basement membrane and the sarcolemma (10) . It is these satellite cells that are capable of proliferating in vitro (11, 12) and are probably responsible for postnatal muscle regeneration and fiber growth in vivo. We have previously used pure populations of myoblasts obtained by these methods to study differentiated muscle properties and observed no differences between normal and DMD myotube morphology or function (13, 14) .
We report here evidence of a cellular abnormality in the morphology and proliferative capacity of undifferentiated muscle satellite cells from patients with DMD. (9, 13, 14) . The proliferation or fusion of cells at both clonal and high density was manipulated by changes in the composition of the culture medium, as described (9) .
Statistical Analysis. From the growth curves, the average doubling time for each normal and DMD muscle clone was determined. The distribution of doubling times for normal and DMD clones was compared as a function of age by rank order analysis using the Mann-Whitney U test (17, 18) .
RESULTS
The total cell yield from normal and dystrophic muscle was compared. For (19) . By contrast, the proportion of cells isolated from DMD muscle that were myoblasts decreased with increasing age of patient, from approximately 90% to 30% of total clones. Concurrently, the proportion of fibroblasts increased from 10% to 70%.
The overall reduction in cell yield and the shift in the proportion of cell types obtained from DMD samples were due to a deficit of myoblasts. This is clear from an analysis of the absolute yield of the two cell types, myoblasts and fibroblasts ( (Fig. 2) . These cells are large, flat, and distended and are clearly distinguished from normal myoblasts, which are smaller, refractile, and actively dividing. Clones of these cells, which typically reach a few hundred cells in size and then cease dividing, fuse to form multinucleated myotubes when exposed to fusion medium. Thus, they appear to be myoblasts with an altered morphology and defective proliferative capacity. The proportion of total DMD myoblast clones exhibiting this morphology increased from 2% to 93% over a 12-yr age span ( The growth kinetics of clones derived from the myoblasts of normal and DMD muscle biopsies also differed. Representative growth curves of clones from biopsies of a typical normal individual (S.W.), a 5-yr-old DMD patient (W. M.), and a 14-yrold DMD patient (M.B.) are shown in Fig. 3 . The slopes of the growth curves for the myoblasts of a given normal sample are very similar and typically exponential, whereas those for the myoblasts of a dystrophic sample from a young patient are highly heterogeneous and often are not exponential. This is due to the presence of D cells. By 14 yr of age almost no clones exhibit normal growth kinetics.
We determined the average doubling times for 142 muscle clones from four normal and four DMD samples. The doubling time for the normal myoblasts was 16.3 ± 1.6 hr, as previously observed (9) , whereas the doubling time for the DMD myoblasts was increased and highly variable. In contrast, the fibroblast clones from eight DMD patients had normal growth kinetics and a doubling time of 17.6 ± 0.4 hr. We then scored the proportion of muscle clones with doubling times >25 hr for donors of different ages (Fig. 4 Left). The distribution of doubling times for DMD and normal clones were significantly different by the Mann-Whitney U test (P < 0.01). The proportion of DMD muscle clones with long doubling times increased to nearly 80% as the age of the muscle donor increased, whereas only one normal clone had a doubling time >25 hr. Thus, DMD myoblasts, but not fibroblasts, have prolonged generation times in culture. A similar age-related increase in the proportion of muscle clones with altered morphology was apparent for the same group of DMD patients (Fig. 4 Right). At (9) . It seems reasonable that this proliferative potential is not just reserved for muscle regeneration but is also utilized for muscle growth. During the first 13 yr of human life, a 6-fold increase in muscle fiber diameter occurs (23) , which is paralleled by an increase in the number of nuclei per unit fiber (21) . In the mouse and rat, similar increases in the size and nuclear number of muscle fibers accompany postnatal development (24) (25) (26) . Because no nuclear division occurs within differentiated multinucleated mvotubes Medical Sciences: Blau et al. 4860 Medical Sciences: Blau et al (27, 28) , these additional nuclei must be exogenous in origin and contributed by the division and fusion of adjacent satellite cells.
Our results provide evidence in support of a primary defect in the undifferentiated myoblasts of DMD muscle. First, the yield of myoblasts, but not fibroblasts, from DMD biopsies of the vastus lateralis muscle is decreased by 95%, irrespective of the age of the donor. In addition, in two samples (B.L. and R.B., Table 1 , other donors) in which muscle regeneration was minimal, a significant proportion of myoblasts with the altered phenotype was obtained. B.L. was an obligate carrier of DMD and among the one-third of carriers whose muscle biopsy and serum creatine kinase activity were normal and therefore not diagnosable by current methods (1) . Accordingly, the total cell yield per 0.1 g of biopsy and the ratio of myoblast to fibroblast cells obtained from B.L. were within the normal range. However, 5% of her myoblasts had an altered phenotype, a proportion significantly greater than normal. This observation presents the possibility of a method of detection for this group of carriers. From the DMD patient R.B., two muscles were biopsied, the semimembranosus, which was only moderately affected, and the vastus lateralis, which was severely affected both clinically and histologically. Accordingly, the total cell yield and myoblast to fibroblast ratio for the semimembranosus closely approximated those values observed for the cells of normal samples and differed markedly from the vastus lateralis. However, the proportion of muscle cells with a diseased phenotype was similar (56% and 41%) for these two muscles. In both of these cases, a significant proportion of defective myoblasts was obtained from muscles that were not undergoing extensive myofiber degeneration. Thus, their appearance is not likely to be secondary to the proliferative demands upon the myoblasts during muscle regeneration.
These results lead us to conclude that there is a basic defect in the undifferentiated satellite myoblasts of muscle tissue from individuals with the gene for DMD. The proliferative capacity of these cells is severely impaired and the resulting decrease in myogenic cell yield limits muscle fiber growth. Prenatal muscle development appears to be minimally affected, because the histology of muscle and serum creatine kinase levels of second trimester fetuses at risk for DMD were found to be indistinguishable from those of normal controls (29) . As a result, DMD can presently only be definitively diagnosed after birth. These observations suggest a developmental basis for the disease. In view of our findings, this could be an inability of DMD myoblasts to mature in response to a specific developmental signal. Alternatively, like erythropoietic cells (30) (31) (32) (33) , there may be subsets of muscle precursor cells, or myoblasts, with different roles at different stages of development. Individuals with DMD may lack or have a defective myoblast subset. These myoblasts may be essential to postnatal development and a deficit could result in impaired muscle growth leading to the pathogenesis characteristic of the disease.
